On 12 November 2026, ENVISION GREEN (01783.HK) guided to interim net profit above HK$55 million, versus about HK$14.4 million, on revenue above HK$3.5 billion.
On 12 November 2026, CHK OIL (00632.HK) extended its cooperation project MOU with Aral Petroleum Capital LLP by six months to 12 May 2027, its third extension.
On 12 November 2026, TYK MEDICINES-B (02410.HK) agreed to issue 76 million new H shares at HK$3.80 each, a 7.32% discount, raising HK$288.42 million net.
On 13 November 2026, EVEREST MED (01952.HK) said China's NMPA approved a 100mg strength of XERAVA (eravacycline) for complicated intra-abdominal infections.
On 12 Nov 2026, CHOW SANG SANG (00116.HK) disclosed unauthorised access to its systems detected on 9 November, with customer and staff data possibly extracted.
On 12 November 2026, Eli Radiopharma closed a Series A round of nearly RMB 400 million co-led by Huagai Capital and Bayland Capital; amount undisclosed.
On 12 Nov 2026, REMEGEN (09995.HK) amended its Vor Bio licence to add RC298, receiving about US$56m upfront and up to US$300m in development milestones.
On 12 Nov 2026, JD-SW (09618.HK) completed its CECONOMY takeover at EUR4.60 per share, paying EUR1.335bn for 59.8% and consolidating it from that date.
Recently, Lingjie Aviation (Infini Aero, unlisted) closed a RMB 10 million-level angel round solely funded by Shanghai Huxiang Investment; terms undisclosed.
On 12 Nov 2026, MEIG (03268.HK) said associate HOSIN ELEC (02681.HK) listed in Hong Kong at HKD 72.83; its stake may lift 2026 profit by RMB 88.47 million.
On 12 Nov 2026, CHINA POWER (02380.HK) said it issued a second RMB 1.5 billion perpetual medium term note tranche in China on 11 November at a 1.73% coupon.
On 12 Nov 2026, FOSUN PHARMA (02196.HK) said unit Fosun Kite began a Phase II trial of FKC516, a CD20 CAR-T therapy, in relapsed B-cell NHL in the PRC.
On November 12, the HSI fell 1.26% and the HSTECH 2.36%. TRANSSION led Stock Connect gainers at 22.47% as southbound funds bought HK$5.846 billion net.
On November 12, the HSI fell 1.26% and the HSTECH 2.36% as chip names bucked the trend; ILUVATAR COREX rose 8.85%, while 17 of 20 AI concept stocks declined.
On November 12, 2026, AMICRO topped the gainers with a rise of 38.18%; Z.AI led liquidity with turnover of HKD 3.801 billion; METIS TECHBIO-P and IMPACT THERAP-B will see lock-up expiries tomorrow.
On November 12, Hong Kong stocks retreated, the Hang Seng Index down 1.26% on turnover of 202.7 billion HKD and southbound net buying of 5.846 billion HKD.
